Evidence map›Paper›PMID 34205546›Full record

ArticleCancers2021

Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study.

Cristina Díaz Del Arco, Luis Ortega Medina, Lourdes Estrada Muñoz, Elena Molina Roldán, M Ángeles Cerón Nieto, Soledad García Gómez de Las Heras, M Jesús Fernández Aceñero

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic strategy for scirrhous type gastric cancer.Japanese journal of clinical oncology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristina Díaz Del ArcoDepartment of Surgical Pathology, Psychiatry and Pathology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0002-6100-4967
Luis Ortega MedinaDepartment of Surgical Pathology, Psychiatry and Pathology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Lourdes Estrada MuñozDepartment of Pathology, Hospital Rey Juan Carlos, Móstoles, 28933 Madrid, Spain.
Elena Molina RoldánDepartment of Pathology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
M Ángeles Cerón NietoDepartment of Pathology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
Soledad García Gómez de Las HerasDepartment of Basic Medical Sciences, School of Medicine, Rey Juan Carlos University, Móstoles, 28933 Madrid, Spain.
M Jesús Fernández AceñeroDepartment of Surgical Pathology, Psychiatry and Pathology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0002-2439-3553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most studies on the clinicopathological impact of Borrmann classification for gastric cancer (GC) have been performed in Asian patients with type IV tumors, and immunohistochemical features of Borrmann types have scarcely been analyzed. We assessed the clinicopathological, molecular features and prognostic value of Borrmann types in all patients with advanced GC resected in a Western institution (

Indexed as

Borrmann classificationclinicopathologicalgastric cancergross morphologymolecularprognosis

Identifiers

PMID34205546
PMCPMC8234739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.